X95-50126. Determination of Regulatory Review Period for Purposes of Patent Extension; NetrexinSUPTM  

  • [Federal Register Volume 60, Number 17 (Thursday, January 26, 1995)]
    [Corrections]
    [Page 5252]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: X95-50126]
    
    
    
                                                        VOL. 60, NO. 17
    
                                             Thursday, January 26, 1995
    
    Federal Register/Vol. 60, No. 17/Thursday, January 26, 1995/
    Corrections
    [[Page 5252]]
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 94E-0099]
    
    
    Determination of Regulatory Review Period for Purposes of Patent 
    Extension; NetrexinTM
    
    Correction
    
        In the correction of notice document 94-21280 appearing on page 
    50793 in the issue of Wednesday, October 5, 1994, in the third column, 
    in the second line, ``fourth'' should read ``third''.
    
    BILLING CODE 1505-01-D
    
    

Document Information

Published:
01/26/1995
Department:
Food and Drug Administration
Entry Type:
Correction
Document Number:
X95-50126
Pages:
5252-5252 (1 pages)
Docket Numbers:
Docket No. 94E-0099
PDF File:
x95-50126.pdf